tiprankstipranks
Firefly Neuroscience (AIFF)
NASDAQ:AIFF
US Market
Want to see AIFF full AI Analyst Report?

Firefly Neuroscience (AIFF) Price & Analysis

380 Followers

AIFF Stock Chart & Stats

$1.11
$0.07(6.31%)
At close: 4:00 PM EDT
$1.11
$0.07(6.31%)

Bulls Say, Bears Say

Bulls Say
Revenue Growth & Gross MarginSustained TTM revenue growth (~+38.7%) combined with ~52% gross margin implies the product can scale with attractive unit economics. Over the next 2–6 months this supports reinvestment in R&D and commercialization while giving a clearer path to operating leverage if fixed costs are controlled.
Debt-free Balance SheetHaving no debt and positive shareholders' equity (~$8.4M) reduces solvency risk and interest expense constraints. This durable structural strength gives the company financing flexibility and less immediate pressure on cash flows while it pursues additional capital or operational improvements.
Governance & Talent IncentivesExpanding equity awards while tightening authorized shares signals a dual focus on attracting/retaining technical talent and on clearer capital structure governance. Structurally this can strengthen execution by aligning employee incentives and reducing long-term authorization overhang for shareholders.
Bears Say
High Operating Cash BurnPersistent negative operating and free cash flow (~-$7.6M / -$7.8M TTM) shows the business is converting losses into real cash outflows. Over the next several months this creates runway pressure and forces reliance on external financing unless operational cash generation improves materially.
Very Weak ProfitabilityExtremely negative net margin (~-565%) and sizable operating losses indicate the cost base far exceeds current revenue. Structurally this means meaningful scaling or sustained cost reductions are required to achieve profitability, representing execution risk over a 2–6 month horizon.
Financing UncertaintyThe termination of a planned private placement reduces near-term access to committed capital and increases uncertainty around funding timing and terms. This structural funding gap may force more dilutive or constrained financing choices and impact growth plans and hiring.

Firefly Neuroscience News

AIFF FAQ

What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $3.63 in the past 12 months.
    What is Firefly Neuroscience’s market cap?
    Firefly Neuroscience’s market cap is $17.10M.
      When is Firefly Neuroscience’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Firefly Neuroscience’s earnings last quarter?
      Firefly Neuroscience released its earnings results on May 14, 2024. The company reported -$0.335 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.335.
        Is Firefly Neuroscience overvalued?
        According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Firefly Neuroscience pay dividends?
          Firefly Neuroscience does not currently pay dividends.
          What is Firefly Neuroscience’s EPS estimate?
          Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Firefly Neuroscience have?
          Firefly Neuroscience has 15,690,316 shares outstanding.
            What happened to Firefly Neuroscience’s price movement after its last earnings report?
            Firefly Neuroscience reported an EPS of -$0.335 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
              Which hedge fund is a major shareholder of Firefly Neuroscience?
              Currently, no hedge funds are holding shares in AIFF
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Firefly Neuroscience

                Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

                Firefly Neuroscience (AIFF) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Irhythm Technologies
                NeuroOne Medical Technologies
                Cognition Therapeutics

                Ownership Overview

                11.76%1.29%4.22%81.71%
                11.76% Insiders
                4.22% Other Institutional Investors
                81.71% Public Companies and
                Individual Investors
                Popular Stocks